title: Enablers of the implementation of tissue plasminogen activator in acute stroke care: a cross-sectional survey.
abstract: OBJECTIVE
  To assess emergency physicians' perceptions of individual and system enablers to the use of tissue Plasminogen Activator in acute stroke.
  
  
  METHODS
  Australian fellows and trainees of Australasian College for Emergency Medicine completed a 57-item online survey assessing enablers to implementation of evidence-based practice across six domains: knowledge, skills, modelling, monitoring, feedback, and maintenance. Demographic and workplace characteristics were obtained. Descriptive statistics were calculated to describe demographic and workplace characteristics of responders, and survey responses. Each domain received an overall score (%) based on the number of responders agreeing with all items within the domain.
  
  
  RESULTS
  A total of 429 (13%) Australasian College for Emergency Medicine members responded. 17.7% of respondents reported they and/or their workplace met all knowledge-related enablers, however only 2.3% had all skill-related enablers in place. Of respondents who decide which patients receive tissue Plasminogen Activator treatment, 18.1% agreed that all maintenance-related enablers are in place at their hospital, compared to 6.6% for those who do not decide which patients receive tissue Plasminogen Activator treatment. None of the respondents had all items in place cross all domains.
  
  
  CONCLUSIONS
  Even when allowing for the low response rate, it seems likely there is a lack of individual and system enablers supporting the implementation of best-practice stroke care in a number of Australian hospitals. Quality improvement programs could target all domains, particularly the skills-training and feedback emergency physicians receive, to aid implementation of tissue Plasminogen Activator treatment for acute stroke.
authors.affiliation: Priority Research Centre for Health Behaviour, Hunter Medical Research Institute, University of Newcastle, Callahan, Australia.
authors.forename: Alice
authors.initials: A
authors.lastname: Grady
authors.affiliation: Priority Research Centre for Health Behaviour, Hunter Medical Research Institute, University of Newcastle, Callahan, Australia.
authors.forename: Jamie
authors.initials: J
authors.lastname: Bryant
authors.affiliation: Priority Research Centre for Health Behaviour, Hunter Medical Research Institute, University of Newcastle, Callahan, Australia.
authors.forename: Mariko
authors.initials: M
authors.lastname: Carey
authors.affiliation: Priority Research Centre for Health Behaviour, Hunter Medical Research Institute, University of Newcastle, Callahan, Australia.
authors.forename: Chris
authors.initials: C
authors.lastname: Paul
authors.affiliation: Priority Research Centre for Health Behaviour, Hunter Medical Research Institute, University of Newcastle, Callahan, Australia.
authors.forename: Rob
authors.initials: R
authors.lastname: Sanson-Fisher
mesh_terms: D000208:Acute Disease; D000328:Adult; D001291:Attitude of Health Personnel; D003430:Cross-Sectional Studies; D004635:Emergency Medicine; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006761:Hospitals; D006801:Humans; D008297:Male; D010820:Physicians; D058996:Quality Improvement; D020521:Stroke / Q000188:drug therapy*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator